Cleaner samples help to support donor cell acceptance
How Curiox Can Help
Flow cytometric crossmatch (FCXM) is used primarily in transplantation medicine to assess the compatibility between a donor and a recipient. It is a highly sensitive method that detects antibodies in the recipient’s blood that may react negatively towards the donor’s cells, potentially leading to graft rejection.
This flow cytometry-based method provides a sensitive and quantitative measure of antibody binding. It identifies pre-formed antibodies in the recipient and is essential for evaluating compatibility for organ transplantation.
With FCXM, either T or B cells are isolated from the donor’s blood, and serum is collected from the recipient. The donor lymphocytes are incubated with the recipient’s serum allowing antibodies to bind to the donor cells. Fluorescently labeled secondary antibodies that bind to human immunoglobulins (IgG) are added. These secondary antibodies attach to recipient antibodies that have been bound to donor cells. This mixture is then analyzed by flow cytometry.
By preventing cross-contamination and safely handling blood-borne pathogens, automated sample preparation by Curiox C-FREE and Curiox Laminar Wash technologies enable high-resolution HLA typing. This streamlined workflow results in cleaner, higher quality data.
The Laminar Washer is safer than flicking (minimal exposure to infectious materials) and requires less space than centrifuges. Our samples are fragile and prone to cell death, but this system promotes cell viability and stability, and has proven consistency at low cell counts producing reliable and reproducible results while also preventing cross-contamination of samples.
Blanca Ponce-Ngo
Organization
Copyright © 2024 Curiox Biosystems. All rights reserved.